(Q51853249)

14 April 2018

title

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. (English)

1 reference

14 April 2018

0 references

Elizabeth M Brown

3

0 references

David N. Fisman

8

object named as

David N Fisman

1 reference

14 April 2018

author name string

Laura M Kinlin

1

1 reference

14 April 2018

Frances Jamieson

2

1 reference

14 April 2018

Shirley Brown

4

1 reference

14 April 2018

Prasad Rawte

5

1 reference

14 April 2018

Sharon Dolman

6

1 reference

14 April 2018

Steven J Drews

7

1 reference

14 April 2018

language of work or name

English

0 references

publication date

30 January 2009

1 reference

14 April 2018

published in

Vaccine

1 reference

14 April 2018

volume

27

1 reference

14 April 2018

issue

11

1 reference

14 April 2018

page(s)

1735-1740

1 reference

14 April 2018

Bacterial meningitis in the United States in 1995. Active Surveillance Team

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Epidemiology and pathogenesis of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

7 January 2021

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Conquering the meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Opportunities for control of meningococcal disease in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Modeling repeated count data subject to informative dropout

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Immunization update 2005: Stepping forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Impact of meningococcal C conjugate vaccine in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

The impact of meningococcal serogroup C conjugate vaccine in Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

The UK Hib vaccine experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

Meningococcal conjugate vaccines: new opportunities and new challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.026

10.1016/J.VACCINE.2009.01.026

7 January 2021

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018